Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function : A Randomized Controlled Trial
© 2021 S. Karger AG, Basel..
INTRODUCTION: Large randomized trials testing the effect of a multifactorial weight-loss lifestyle intervention including Mediterranean diet (MedDiet) on renal function are lacking. Here, we evaluated the 1-year efficacy of an intensive weight-loss intervention with an energy-reduced MedDiet (erMedDiet) plus increased physical activity (PA) on renal function.
METHODS: Randomized controlled "PREvención con DIeta MEDiterránea-Plus" (PREDIMED-Plus) trial is conducted in 23 Spanish centers comprising 208 primary care clinics. Overweight/obese (n = 6,719) adults aged 55-75 years with metabolic syndrome were randomly assigned (1:1) to an intensive weight-loss lifestyle intervention with an erMedDiet, PA promotion, and behavioral support (intervention) or usual-care advice to adhere to an energy-unrestricted MedDiet (control) between September 2013 and December 2016. The primary outcome was 1-year change in estimated glomerular filtration rate (eGFR). Secondary outcomes were changes in urine albumin-to-creatinine ratio (UACR), incidence of moderately/severely impaired eGFR (<60 mL/min/1.73 m2) and micro- to macroalbuminuria (UACR ≥30 mg/g), and reversion of moderately (45 to <60 mL/min/1.73 m2) to mildly impaired GFR (60 to <90 mL/min/1.73 m2) or micro- to macroalbuminuria.
RESULTS: After 1 year, eGFR declined by 0.66 and 1.25 mL/min/1.73 m2 in the intervention and control groups, respectively (mean difference, 0.58 mL/min/1.73 m2; 95% CI: 0.15-1.02). There were no between-group differences in mean UACR or micro- to macroalbuminuria changes. Moderately/severely impaired eGFR incidence and reversion of moderately to mildly impaired GFR were 40% lower (HR 0.60; 0.44-0.82) and 92% higher (HR 1.92; 1.35-2.73), respectively, in the intervention group.
CONCLUSIONS: The PREDIMED-Plus lifestyle intervention approach may preserve renal function and delay CKD progression in overweight/obese adults.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
American journal of nephrology - 52(2021), 1 vom: 14., Seite 45-58 |
Sprache: |
Englisch |
---|
Links: |
---|
Anmerkungen: |
Date Completed 04.11.2021 Date Revised 04.11.2021 published: Print-Electronic ISRCTN: ISRCTN89898870 Citation Status MEDLINE |
---|
doi: |
10.1159/000513664 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321173872 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321173872 | ||
003 | DE-627 | ||
005 | 20231225175241.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000513664 |2 doi | |
028 | 5 | 2 | |a pubmed24n1070.xml |
035 | |a (DE-627)NLM321173872 | ||
035 | |a (NLM)33556935 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Díaz-López, Andrés |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function |b A Randomized Controlled Trial |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.11.2021 | ||
500 | |a Date Revised 04.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a ISRCTN: ISRCTN89898870 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 S. Karger AG, Basel. | ||
520 | |a INTRODUCTION: Large randomized trials testing the effect of a multifactorial weight-loss lifestyle intervention including Mediterranean diet (MedDiet) on renal function are lacking. Here, we evaluated the 1-year efficacy of an intensive weight-loss intervention with an energy-reduced MedDiet (erMedDiet) plus increased physical activity (PA) on renal function | ||
520 | |a METHODS: Randomized controlled "PREvención con DIeta MEDiterránea-Plus" (PREDIMED-Plus) trial is conducted in 23 Spanish centers comprising 208 primary care clinics. Overweight/obese (n = 6,719) adults aged 55-75 years with metabolic syndrome were randomly assigned (1:1) to an intensive weight-loss lifestyle intervention with an erMedDiet, PA promotion, and behavioral support (intervention) or usual-care advice to adhere to an energy-unrestricted MedDiet (control) between September 2013 and December 2016. The primary outcome was 1-year change in estimated glomerular filtration rate (eGFR). Secondary outcomes were changes in urine albumin-to-creatinine ratio (UACR), incidence of moderately/severely impaired eGFR (<60 mL/min/1.73 m2) and micro- to macroalbuminuria (UACR ≥30 mg/g), and reversion of moderately (45 to <60 mL/min/1.73 m2) to mildly impaired GFR (60 to <90 mL/min/1.73 m2) or micro- to macroalbuminuria | ||
520 | |a RESULTS: After 1 year, eGFR declined by 0.66 and 1.25 mL/min/1.73 m2 in the intervention and control groups, respectively (mean difference, 0.58 mL/min/1.73 m2; 95% CI: 0.15-1.02). There were no between-group differences in mean UACR or micro- to macroalbuminuria changes. Moderately/severely impaired eGFR incidence and reversion of moderately to mildly impaired GFR were 40% lower (HR 0.60; 0.44-0.82) and 92% higher (HR 1.92; 1.35-2.73), respectively, in the intervention group | ||
520 | |a CONCLUSIONS: The PREDIMED-Plus lifestyle intervention approach may preserve renal function and delay CKD progression in overweight/obese adults | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Dietary intervention | |
650 | 4 | |a Glomerular filtration rate | |
650 | 4 | |a Kidney function | |
650 | 4 | |a Mediterranean diet | |
650 | 4 | |a PREDIMED-Plus | |
650 | 4 | |a Weight loss | |
700 | 1 | |a Becerra-Tomás, Nerea |e verfasserin |4 aut | |
700 | 1 | |a Ruiz, Verónica |e verfasserin |4 aut | |
700 | 1 | |a Toledo, Estefania |e verfasserin |4 aut | |
700 | 1 | |a Babio, Nancy |e verfasserin |4 aut | |
700 | 1 | |a Corella, Dolores |e verfasserin |4 aut | |
700 | 1 | |a Fitó, Montse |e verfasserin |4 aut | |
700 | 1 | |a Romaguera, Dora |e verfasserin |4 aut | |
700 | 1 | |a Vioque, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Alonso-Gómez, Ángel M |e verfasserin |4 aut | |
700 | 1 | |a Wärnberg, Julia |e verfasserin |4 aut | |
700 | 1 | |a Martínez, J Alfredo |e verfasserin |4 aut | |
700 | 1 | |a Serra-Majem, Luís |e verfasserin |4 aut | |
700 | 1 | |a Estruch, Ramon |e verfasserin |4 aut | |
700 | 1 | |a Tinahones, Francisco J |e verfasserin |4 aut | |
700 | 1 | |a Lapetra, José |e verfasserin |4 aut | |
700 | 1 | |a Pintó, Xavier |e verfasserin |4 aut | |
700 | 1 | |a Tur, Josep A |e verfasserin |4 aut | |
700 | 1 | |a López-Miranda, José |e verfasserin |4 aut | |
700 | 1 | |a Cano Ibañez, Naomi |e verfasserin |4 aut | |
700 | 1 | |a Delgado-Rodríguez, Miguel |e verfasserin |4 aut | |
700 | 1 | |a Matía-Martín, Pilar |e verfasserin |4 aut | |
700 | 1 | |a Daimiel, Lidia |e verfasserin |4 aut | |
700 | 1 | |a de Paz, Jose Antonio |e verfasserin |4 aut | |
700 | 1 | |a Vidal, Josep |e verfasserin |4 aut | |
700 | 1 | |a Vázquez, Clotilde |e verfasserin |4 aut | |
700 | 1 | |a Ruiz-Canela, Miguel |e verfasserin |4 aut | |
700 | 1 | |a Bulló, Mònica |e verfasserin |4 aut | |
700 | 1 | |a Sorlí, José V |e verfasserin |4 aut | |
700 | 1 | |a Goday, Albert |e verfasserin |4 aut | |
700 | 1 | |a Fiol, Miquel |e verfasserin |4 aut | |
700 | 1 | |a García-de-la-Hera, Manoli |e verfasserin |4 aut | |
700 | 1 | |a Tojal Sierra, Lucas |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Farinós, Napoleón |e verfasserin |4 aut | |
700 | 1 | |a Zulet, Maria Ángeles |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Villegas, Almudena |e verfasserin |4 aut | |
700 | 1 | |a Sacanella, Emilio |e verfasserin |4 aut | |
700 | 1 | |a Fernández-García, José Carlos |e verfasserin |4 aut | |
700 | 1 | |a Santos-Lozano, José Manuel |e verfasserin |4 aut | |
700 | 1 | |a Gimenez-Gracia, Miquel |e verfasserin |4 aut | |
700 | 1 | |a Del Mar Bibiloni, Maria |e verfasserin |4 aut | |
700 | 1 | |a Diez-Espino, Javier |e verfasserin |4 aut | |
700 | 1 | |a Ortega-Azorin, Carolina |e verfasserin |4 aut | |
700 | 1 | |a Castañer, Olga |e verfasserin |4 aut | |
700 | 1 | |a Morey, Marga |e verfasserin |4 aut | |
700 | 1 | |a Torres-Collado, Laura |e verfasserin |4 aut | |
700 | 1 | |a Sorto Sanchez, Carolina |e verfasserin |4 aut | |
700 | 1 | |a Muñoz, Miguel Ángel |e verfasserin |4 aut | |
700 | 1 | |a Ros, Emilio |e verfasserin |4 aut | |
700 | 1 | |a Martinez-Gonzalez, Miguel A |e verfasserin |4 aut | |
700 | 1 | |a Salas-Salvadó, Jordi |e verfasserin |4 aut | |
700 | 0 | |a PREDIMED-Plus Investigators |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of nephrology |d 1991 |g 52(2021), 1 vom: 14., Seite 45-58 |w (DE-627)NLM01263736X |x 1421-9670 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2021 |g number:1 |g day:14 |g pages:45-58 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000513664 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2021 |e 1 |b 14 |h 45-58 |